FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Is Mom late on bills? Could be sign of dementia, report finds
By
Kristen Fischer
Jun 05, 2024
Older adults who fall behind on paying their bills may have early signs of dementia and be susceptible to further financial risks, according to a recent report.
Study spots brain clusters linked to subjective memory complaints
By
Kristen Fischer
May 23, 2024
People with subjective memory complaints include two subgroups, and being in the lower performance cluster increased the risk for cognitive impairment, according to a study published Thursday in Alzheimer’s...
Having a good listener in one’s life may help slow cognitive decline: study
By
Alicia Lasek
Aug 18, 2021
Older adults who have regular interactions with active listeners are more likely to have cognitive functioning that contradicts evidence of dementia-related brain changes, a new study finds.
Early Alzheimer’s diagnosis may unintentionally hamper social engagement
By
Alicia Lasek
Nov 23, 2021
Clinicians should identify strategies to alleviate the social impacts of dementia diagnoses and encourage patients to mobilize informal support networks, researchers say.
CMS shares new coverage details for Alzheimer’s drug Leqembi
By
Alicia Lasek
Jun 26, 2023
On the eve of an FDA decision, CMS has released new information about the detailed patient data that clinicians must provide to ensure Medicare coverage when prescribing Leqembi.
MA enrollees with dementia report poor quality of care: study
By
Alicia Lasek (f3)
May 09, 2022
Medicare Advantage plans will be more incentivized to address gaps in care if consumer care assessments include more input from enrollees with dementia, investigators say.
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
BREAKING: First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 27, 2021
The first set of guidelines has been published for clinicians who wish to prescribe the new drug aducanumab (Aduhelm) and to properly monitor its administration. The recommendations fill the gaps between...